APA (7th ed.) Citation

Dutour, A., Abdesselam, I., Ancel, P., Kober, F., Mrad, G., Darmon, P., . . . Gaborit, B. (2016). Exenatide decreases liver fat content and epicardial adipose tissue in patients with obesity and type 2 diabetes: A prospective randomized clinical trial using magnetic resonance imaging and spectroscopy. Diabetes, obesity & metabolism, 18(9), 882-891. https://doi.org/10.1111/dom.12680

Chicago Style (17th ed.) Citation

Dutour, A., et al. "Exenatide Decreases Liver Fat Content and Epicardial Adipose Tissue in Patients with Obesity and Type 2 Diabetes: A Prospective Randomized Clinical Trial Using Magnetic Resonance Imaging and Spectroscopy." Diabetes, Obesity & Metabolism 18, no. 9 (2016): 882-891. https://doi.org/10.1111/dom.12680.

MLA (9th ed.) Citation

Dutour, A., et al. "Exenatide Decreases Liver Fat Content and Epicardial Adipose Tissue in Patients with Obesity and Type 2 Diabetes: A Prospective Randomized Clinical Trial Using Magnetic Resonance Imaging and Spectroscopy." Diabetes, Obesity & Metabolism, vol. 18, no. 9, 2016, pp. 882-891, https://doi.org/10.1111/dom.12680.